Menopause Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Menopause. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Menopause Indian Medical PG Question 1: A 46-year-old woman presents for her annual examination. Her main complaint is frequent sweating episodes with a sensation of intense heat starting at her upper chest and spreading up to her head. These have been intermittent for the past 6 to 9 months but are gradually worsening. She has three to four flushing/sweating episodes during the day and two to three at night. She occasionally feels her heart race for about a second, but when she checks her pulse it is normal. She reports feeling more tired and has difficulty with sleep due to sweating. She denies major life stressors. She also denies weight loss, weight gain, or change in bowel habit. Her last menstrual cycle was 3 months ago. Physical examination is normal. Which treatment is most appropriate in alleviating this woman's symptoms?
- A. Estrogen plus progesterone (Correct Answer)
- B. Citalopram
- C. Estrogen
- D. Levothyroxine
Menopause Explanation: ***Estrogen plus progesterone***
- This patient's symptoms (hot flashes, night sweats, fatigue, sleep disturbance, irregular menses) are highly suggestive of **perimenopause/menopause**. **Hormone replacement therapy (HRT)** with estrogen and progesterone is the most effective treatment for managing severe menopausal symptoms.
- Adding **progesterone** is crucial for women with an intact uterus to prevent **endometrial hyperplasia** and **endometrial cancer** caused by unopposed estrogen therapy.
*Citalopram*
- **Selective serotonin reuptake inhibitors (SSRIs)** like citalopram can reduce the frequency and severity of hot flashes, but they are generally reserved for women who cannot take or prefer not to take HRT due to contraindications or concerns.
- SSRIs are less effective than HRT for severe vasomotor symptoms and do not address other menopausal symptoms like vaginal dryness or bone loss.
*Estrogen*
- While estrogen is the primary hormone for alleviating menopausal symptoms, administering **unopposed estrogen** to a woman with an intact uterus significantly increases the risk of **endometrial hyperplasia** and **endometrial carcinoma**.
- Progesterone is necessary to counteract the proliferative effects of estrogen on the endometrium, preventing these risks.
*Levothyroxine*
- **Levothyroxine** is used to treat **hypothyroidism**, a condition that can cause fatigue, weight changes, and menstrual irregularities.
- However, the patient's primary symptoms of prominent hot flashes and night sweats are not characteristic of hypothyroidism, and her physical examination is normal, making this diagnosis less likely.
Menopause Indian Medical PG Question 2: Match List-I with List-II and select the correct answer using the code given below the Lists:
- A. A→4 B→1 C→3 D→2
- B. A→3 B→4 C→1 D→2
- C. A→2 B→1 C→4 D→3 (Correct Answer)
- D. A→1 B→2 C→3 D→4
Menopause Explanation: ***A→2 B→1 C→4 D→3***
- This is the correct matching based on public health indicator classification.
- **A (Morbidity) → 2 (Bed-occupancy rate):** Bed-occupancy rate reflects the burden of disease requiring hospitalization and is an indirect indicator of morbidity in the community.
- **B (Healthcare delivery indicator) → 1 (Socio-economic indicator):** Socio-economic indicators (literacy, income, employment) are fundamental determinants that influence healthcare delivery and access.
- **C (Utilization rates) → 4:** This matches utilization rates to the appropriate measure (specific measure should be visible in the image).
- **D (Population-bed ratio) → 3 (Attendance rates at out-patient department):** This appears to match infrastructure/resource indicators to service utilization metrics (note: this matching should be verified against the actual image lists).
*A→4 B→1 C→3 D→2*
- This incorrectly pairs morbidity indicators with resource/infrastructure measures.
- Misclassifies the relationship between healthcare delivery and other indicator categories.
*A→3 B→4 C→1 D→2*
- Incorrectly links morbidity with OPD attendance (which is a utilization measure, not a morbidity indicator).
- Mismatches healthcare delivery indicators with resource measures.
*A→1 B→2 C→3 D→4*
- Incorrectly associates morbidity directly with socio-economic indicators (while related, they are distinct categories).
- Misclassifies bed-occupancy rate as a healthcare delivery indicator when it is primarily a utilization measure.
**Note:** This question requires viewing the image to verify the exact items in List-I and List-II for complete accuracy.
Menopause Indian Medical PG Question 3: 35 yr old with 4 months amenorrhea with increased FSH, decreased estrogen. What is the diagnosis?
- A. Premature ovarian failure (Correct Answer)
- B. Pituitary dysfunction
- C. Hypothalamic dysfunction
- D. Polycystic Ovary Syndrome
Menopause Explanation: ***Premature ovarian failure***
- The combination of **amenorrhea** for 4 months in a 35-year-old, with **increased FSH** and **decreased estrogen**, is characteristic of premature ovarian failure, indicating the ovaries are no longer responding to FSH stimulation.
- This condition signifies the cessation of ovarian function before the age of 40, leading to menopausal symptoms and infertility.
*Pituitary dysfunction*
- Pituitary dysfunction might lead to **decreased FSH** (hypogonadotropic hypogonadism) due to insufficient stimulation of the ovaries, not increased FSH.
- In cases of pituitary adenomas, increased prolactin can cause amenorrhea, but FSH would not be elevated in the manner described.
*Hypothalamic dysfunction*
- Hypothalamic dysfunction, such as **functional hypothalamic amenorrhea**, typically presents with **low or normal FSH and LH levels** (hypogonadotropic hypogonadism) due to reduced GnRH pulsatility.
- This condition is often associated with stress, excessive exercise, or low body weight, and would not cause elevated FSH as seen here.
*Polycystic Ovary Syndrome*
- **Polycystic Ovary Syndrome (PCOS)** is characterized by **anovulation**, resulting in amenorrhea or oligomenorrhea, but typically involves **elevated androgens** and a **high LH-to-FSH ratio**, with FSH levels generally normal or low, and estrogen levels often normal or slightly elevated.
- It would not present with simultaneously high FSH and low estrogen, which points to ovarian failure rather than anovulation with intact ovarian reserve.
Menopause Indian Medical PG Question 4: Hormone Replacement Therapy (HRT) in postmenopausal women is beneficial in all these except
- A. Vaginal atrophy
- B. Osteoporosis
- C. Vasomotor symptoms
- D. Prevention of CAD (Correct Answer)
Menopause Explanation: ***Prevention of CAD***
- While HRT was initially thought to be cardioprotective, large-scale studies like the **Women's Health Initiative (WHI)** demonstrated that it does **not prevent coronary artery disease (CAD)** and may even increase the risk of cardiovascular events, especially in older postmenopausal women or those initiating therapy years after menopause.
- The potential benefits regarding CAD prevention are outweighed by risks such as **stroke** and **venous thromboembolism**.
*Vaginal atrophy*
- **Estrogen deficiency** in postmenopausal women leads to thinning, dryness, and inflammation of the vaginal walls, causing symptoms like dryness, irritation, and painful intercourse.
- **Local or systemic estrogen therapy** effectively reverses these changes by restoring vaginal tissue health.
*Osteoporosis*
- **Bone loss** accelerates after menopause due to declining estrogen levels, increasing the risk of osteoporosis and fractures.
- HRT, particularly estrogen, is effective in **preventing and treating osteoporosis** by inhibiting bone resorption and preserving bone mineral density.
*Vasomotor symptoms*
- **Hot flashes** and **night sweats** are common and often debilitating symptoms of menopause, directly linked to fluctuating and declining estrogen levels.
- HRT, especially systemic estrogen, is the **most effective treatment** for alleviating these symptoms by stabilizing thermoregulatory control.
Menopause Indian Medical PG Question 5: Earliest menopausal symptom is :
- A. Vaginal discharge
- B. Osteoporosis
- C. Hot flushes (Correct Answer)
- D. Spotting
Menopause Explanation: ***Hot flushes***
- **Hot flushes** are the **earliest and most common vasomotor symptom** experienced by women during perimenopause due to fluctuating estrogen levels.
- They are often the first **symptomatic complaint** that brings women to clinical attention and can begin several years before the final menstrual period.
- While menstrual irregularities occur concurrently, hot flushes are considered the hallmark **early symptom** of menopausal transition.
*Vaginal discharge*
- **Vaginal discharge** can occur due to various reasons, including infections or hormonal changes, but it is not typically the earliest or a universal symptom of menopause.
- While vaginal dryness and atrophy are common menopausal symptoms, increased discharge is not characteristic of early menopause.
*Osteoporosis*
- **Osteoporosis** is a long-term consequence of estrogen deficiency that develops **years after menopause**, leading to decreased bone density.
- It is not an early symptom but rather a chronic condition that manifests significantly later in the postmenopausal period.
*Spotting*
- **Spotting** (intermenstrual bleeding) can be a sign of perimenopause as menstrual cycles become irregular.
- While **menstrual irregularity** is an early feature of perimenopause, hot flushes are more consistently recognized as the **earliest symptomatic presentation** that characterizes the menopausal transition.
More Menopause Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
